Samira Hajigholami
Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
[ 1 ] - Nano packaged Tamoxifen and Curcumin; effective formulation against sensitive and resistant MCF-7 cells
Tamoxifen is routinely used for treatment of Estrogen-positive breast carcinoma. Approximately, 50% of patients with metastatic cancer will develop resistance to Tamoxifen. In this research, Tamoxifen was combined with the anti-cancer compound Curcumin. Diblock nanopolymer was used to package the new formulation of Curcumin and Tamoxifen. Anti-cancer efficacy of the obtained compound was evalua...
[ 2 ] - Nano packaged Tamoxifen and Curcumin; effective formulation against sensitive and resistant MCF-7 cells
Tamoxifen is routinely used for treatment of Estrogen-positive breast carcinoma. Approximately, 50% of patients with metastatic cancer will develop resistance to Tamoxifen. In this research, Tamoxifen was combined with the anti-cancer compound Curcumin. Diblock nanopolymer was used to package the new formulation of Curcumin and Tamoxifen. Anti-cancer efficacy of the obtained compound was evalua...
Co-Authors